DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Magnevist (Gadopentetate) - Joint Range of Motion Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Joint Range of Motion Decreased (102)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) where reactions include joint range of motion decreased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 102   Next >>

Possible Magnevist side effects in 47 year old female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: 47 year old female

Reactions: Fear of Death, Pain, Fear, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Joint Stiffness, Anxiety, Emotional Distress, Anhedonia, Joint Range of Motion Decreased, Injury, Depression, Nervousness, Scar

Drug(s) suspected as cause:
Magnevist



Possible Magnevist side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: 61 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Wheelchair User, Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Paraesthesia, Skin Tightness, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia, Extremity Contracture, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 15 ml (daily dose), once,
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-08-11
    End date: 2000-08-11

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-01-01
    End date: 2005-01-01

Magnevist
    Dosage: 15 ml (daily dose), once,
    Start date: 2001-07-27
    End date: 2001-07-27

Other drugs received by patient: Nephrocaps; Phoslo; Metronidazole; Renagel; Coreg; Prinivil; Atenolol; Warfarin Sodium; Darvocet; Vancocin Hydrochloride; Sodium Bicarbonate; Iron [iron]; Amoxicillin; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Hydrocodone Bitartrate and Acetaminophen; Tylenol with Codein #3; Phoslo; Solivito N [vit C,vit H,b12,b9,b3,pantothenic Ac,b6,b2,b1 Hcl]; Aspirin; Vitamin B6; Coreg; Epogen; Diltiazem; Plendil; Plendil; Lisinopril



Possible Magnevist side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: 58 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Skin Exfoliation, Quality of Life Decreased, Pain, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Injury, Fibrosis, Blood Creatinine Increased, Extremity Contracture, Blister, Muscle Contracture, Rash Papular, Contrast Media Reaction, Skin Disorder, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Deformity, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Burning Sensation, Renal Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist

Other drugs received by patient: Calcium Acetate; Irbesartan; Clonidine; Hydralazine HCL; Visipaque; Visipaque; Glipizide; Ferrous Sulfate TAB; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Metoprolol Tartrate; Sevelamer Hydrochloride; Terazosin Hydrochloride; Dovonex; Contrast Media; Contrast Media; Synthroid; Aspirin; Felodipine; Contrast Media; Lasix; Omniscan; Folic Acid; Iron; Insulin; EPO



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Gadolinium IN Unspecified Drug
    Indication: Osteomyelitis

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Diabetic Foot

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-01-14
    End date: 2005-01-14

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix



Possible Magnevist side effects in 49 year old male

Reported by a lawyer from United States on 2012-08-02

Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased

Drug(s) suspected as cause:
Omniscan

Multihance
    Indication: Product Used FOR Unknown Indication

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-19
    End date: 2006-05-19

Magnevist
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-10-13
    End date: 2006-10-13

Omniscan
    Dosage: 50 ml omniscan+co2
    Indication: Fistulogram
    Start date: 2006-08-04
    End date: 2006-08-04

Gadolinium IN Unspecified Drug
    Start date: 2004-05-19
    End date: 2004-05-19

Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-05
    End date: 2006-08-05

Prohance
    Indication: Computerised Tomogram Head
    Start date: 2004-05-19
    End date: 2004-05-19

Optimark
    Indication: Product Used FOR Unknown Indication

Magnevist
    Dosage: 20 ml, unk
    Start date: 2006-10-17
    End date: 2006-10-17

Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 56 year old female

Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar

Drug(s) suspected as cause:
Optimark
    Indication: Muscular Weakness

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Magnevist
    Indication: Renal Mass

Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 56 year old female

Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased

Drug(s) suspected as cause:
Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Headache

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Magnevist
    Indication: Renal Mass

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]



Possible Magnevist side effects in 79 year old female

Reported by a physician from United States on 2012-07-20

Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan
    Dosage: dose reported as eight 20ml vials (160ml)
    Start date: 2005-09-20
    End date: 2005-09-20

Multihance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Prohance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Multihance
    Indication: Angiogram

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Gadolinium Zeolite
    Start date: 2005-08-16
    End date: 2005-08-16

Omniscan
    Dosage: route reported as ^first via distal port and then via the proximal port^
    Indication: Angiogram
    Start date: 2003-12-04
    End date: 2003-12-04

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2005-08-16
    End date: 2005-08-16

Optimark
    Indication: Angiogram

Gadolinium Zeolite
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2001-03-05
    End date: 2001-03-05

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-05-23
    End date: 2003-05-23

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: dose reported as ^11^ 20ml vials
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-01
    End date: 2005-09-01

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar



Possible Magnevist side effects in 49 year old female

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: 49 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Skin Wrinkling, Joint Stiffness, Oedema Peripheral, Melanocytic Naevus, Fibrosis, Arthrofibrosis, General Physical Health Deterioration, Hypoaesthesia, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Paraesthesia, Skin Tightness, Scar, Abasia, Pain, Joint Contracture, Skin Hyperpigmentation, Muscle Tightness, Tendon Pain, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Injury, Joint Ankylosis, Extremity Contracture, Myocardial Fibrosis, Dyspnoea, Rash Papular, Musculoskeletal Pain, Skin Disorder, Muscular Weakness, Rash Macular, Pulmonary Fibrosis, Arthralgia, Gait Disturbance, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Start date: 2004-05-20
    End date: 2004-05-20

Magnevist
    Start date: 1999-11-09
    End date: 1999-11-09

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-01-30
    End date: 2005-01-30

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1997-04-30
    End date: 1997-04-30

Magnevist
    Start date: 1998-12-31
    End date: 1998-12-31

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1996-10-30
    End date: 1996-10-30

Magnevist
    Start date: 2002-01-30
    End date: 2002-01-30

Magnevist
    Start date: 2005-01-30
    End date: 2005-01-30

Omniscan
    Start date: 2005-03-20
    End date: 2005-03-20

Magnevist
    Start date: 1997-11-17
    End date: 1997-11-17

Magnevist
    Dosage: 9.7 ml, once
    Start date: 2003-03-20
    End date: 2003-03-20

Omniscan
    Dosage: unk

Magnevist
    Start date: 2000-11-08
    End date: 2000-11-08

Other drugs received by patient: Thyroid Therapy; Ferrous Sulfate TAB; Miacalcin; Cytoxan; Oxandrin; Folic Acid; Procardia; Synthroid; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Advair Diskus 100 / 50; Zemplar; Aranesp; Aleve; Prograf; Epogen; Exforge; Activase; Celebrex; Zestril; Renagel; Metoprolol Succinate; Amigen; Prempro; Rocaltrol; Spironolactone; Demadex; Sensipar; Myfortic; Prednisone; Clonidine; Amlodipine Besylate



Possible Magnevist side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf



Possible Magnevist side effects in 51 year old female

Reported by a lawyer from United States on 2012-07-09

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Fistulogram

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Optimark
    Indication: Venogram

Multihance
    Indication: Venogram

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Prohance
    Indication: Venogram

Prohance
    Indication: Fistulogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Magnevist
    Indication: Dialysis Device Insertion

Omniscan
    Indication: Fistulogram

Optimark
    Indication: Fistulogram

Omniscan
    Indication: Venogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-28

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased

Drug(s) suspected as cause:
Optimark
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Multihance
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1998-05-18
    End date: 1998-05-18

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor



Possible Magnevist side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin



Possible Magnevist side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: female, weighing 72.0 kg (158.4 pounds)

Reactions: Pain, Joint Contracture, Quality of Life Decreased, Skin Hyperpigmentation, Myosclerosis, Myalgia, Joint Range of Motion Decreased, Skin Discolouration, Fibrosis, Injury, Depression, Peau D'orange, Pain in Extremity, General Physical Health Deterioration, Skin Disorder, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Plaque, Anxiety, Activities of Daily Living Impaired, DRY Eye, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2001-03-23
    End date: 2001-03-23

Gadolinium IN Unspecified Drug
    Dosage: 8 ml, once
    Indication: Diagnostic Procedure
    Start date: 2000-05-24
    End date: 2000-05-24

Other drugs received by patient: Epogen; Coumadin; Hydrochlorothiazide; Vioxx; Verapamil; Lopid; Oxycontin; Cellcept; Neoral; Nephrocaps; Amitriptyline HCL; Phoslo; Metoprolol; Quinine Sulfate; Sensipar



Possible Magnevist side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Fibrosis, Cellulitis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Rash, Deformity, Skin Tightness, Skin Plaque, Scar, Mobility Decreased, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Other drugs received by patient: Ativan; Biaxin; Acetaminophen; Ciprofloxacin; Nephrocaps; Cyclophosphamide; Etoposide; Neupogen; Neurontin; Warfarin Sodium; Phoslo; Loperamide; Hydroxyzine; Acyclovir; Zoloft; Vitamin K1; Dilaudid; Albumin (Human); Midodrine Hydrochloride; Foltx; Digoxin; Pravachol; Dexamethasone; Epogen; Gentamicin; Ambien; Clonidine; Bicitra; Mucomyst; Magnesium Oxide; Calcijex; Zosyn; Vitamin K1; Adriamycin PFS; Ocean; Reglan; Compazine; Roxanol; Velcade; Allopurinol; Adenosine; Sensipar; Diflucan; Renagel; Ativan; Ativan; Prevacid; Bactrim DS; Simethicone; Norco; Prograf; Tylenol W / Codeine NO. 3; Dexamethasone; Reglan; Plendil; Renaphro; Folic Acid; Aspirin; Plavix; Lisinopril; Metoprolol Tartrate; Levaquin; Vancomycin; Potassium Chloride; Atarax; Oxacillin; Zemplar; Compazine; Senokot



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-07-03
    End date: 2003-07-03

Magnevist

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark

Multihance

Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx



Possible Magnevist side effects in 79 year old male

Reported by a lawyer from United States on 2012-06-05

Patient: 79 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Muscle Atrophy, Quality of Life Decreased, Joint Contracture, Pain, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema, Musculoskeletal Stiffness, Fibrosis, Pain in Extremity, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Muscle Disorder, Mobility Decreased, Skin Fibrosis, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Fistulogram
    Start date: 2005-11-21
    End date: 2005-11-21

Magnevist
    Start date: 2006-08-16
    End date: 2006-08-16

Magnevist
    Start date: 2006-04-16
    End date: 2006-04-16

Other drugs received by patient: Lipitor; Megestrol Acetate; Aspirin; Terazosin HCL; Rena-Vite [ascorbic Acid,vitamin B Nos]; Colchicine; Phoslo; Lasix; Coumadin; Rocaltrol; Acetaminophen; Atenolol; Prednisone; Aspirin; Isosorbide Mononitrate; Nitroglycerin; Warfarin; Allopurinol; Procardia; Prednisone; Allopurinol; Nephro-Vite [vitamins Nos]; Metoprolol Tartrate



Possible Magnevist side effects in 78 year old male

Reported by a consumer/non-health professional from Japan on 2012-06-01

Patient: 78 year old male, weighing 56.0 kg (123.2 pounds)

Reactions: Joint Range of Motion Decreased, Skin Discolouration, Nephrogenic Systemic Fibrosis, Gait Disturbance, Skin Induration, Blood Creatinine Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: 10 ml, once
    Indication: Metastases To Lymph Nodes
    Start date: 2008-07-29
    End date: 2008-07-29

Prohance
    Dosage: 26 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2008-07-17
    End date: 2008-07-17

Other drugs received by patient: Selbex; Omeprazole; SG Granules; Loxonin; Digoxin; Neurotropin [organ Lysate, Standardized]; Metformin Hydrochloride; Olopatadine HCL; Omeprazole; Unasyn; Antebate; Warfarin Sodium; Lendormin; Adalat CC; Lasix; Strong NEO-Minophagen C; Flomox; Celestamine TAB; Atarax; Zefnart



Possible Magnevist side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01

Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)

Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-13
    End date: 1999-10-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2007-03-21
    End date: 2007-03-21

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-11-18
    End date: 2008-11-18

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-28
    End date: 1999-10-28

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-14
    End date: 2006-01-14

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-09-20
    End date: 1999-09-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Fistulogram
    Start date: 1999-10-08
    End date: 1999-10-08

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-04
    End date: 2006-02-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-03-19
    End date: 2008-03-19

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-09-27
    End date: 1999-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-08-13
    End date: 2008-08-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela



Possible Magnevist side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Fatigue, Anhedonia, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Extremity Contracture, Peau D'orange, Pain in Extremity, Excoriation, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Renal
    Start date: 2005-08-25
    End date: 2005-08-25

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Other drugs received by patient: Viagra; Oxycodone Hydrochloride; Lisinopril; Mirapex; Sodium Citrate; Prednisone TAB; Norvasc; Zaroxolyn; Lasix; Compazine; Aspirin; Folic Acid; Spiriva; Calcitriol; Ativan; Cytoxan; Acetaminophen; Pentamidine Isethionate; Albuterol; Calcitonin Salmon; Phoslo; Lexapro; Pravachol; Labetalol HCL; MS Contin; Lopressor; Thiamine; Trazodone HCL; Protonix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Kayexalate; Darbepoetin Alfa; Wellbutrin; Normodyne; Coumadin; Flagyl; Heparin; Magnesium Oxide; Fosamax



Possible Magnevist side effects in 51 year old female

Reported by a lawyer from United States on 2012-05-31

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Dermatitis, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Sclerodactylia, Burning Sensation, Anxiety, Emotional Distress, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Omniscan
    Indication: Venogram

Optimark
    Indication: Venogram

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Magnevist
    Indication: Dialysis Device Insertion

Multihance
    Indication: Fistulogram

Prohance
    Indication: Fistulogram

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Fistulogram

Prohance
    Indication: Venogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Fistulogram

Multihance
    Indication: Venogram

Other drugs received by patient: Levothroid; Atenolol; Vicodin; Immune Globulin NOS; Tramadol HCL; Protonix; Pravachol; Sensipar; Sensipar; Imodium; Immune Globulin NOS; Benadryl; Fosrenol; Nitroglycerin; Corticosteroids; Calcium Carbonate; Renagel; Phoslo; Immune Globulin NOS; Immune Globulin NOS; Loperamide; Protonix; Nephro-Vite [vitamins Nos]; Allopurinol; Allopurinol; Cyclosporine; Acetaminophen; Benadryl; Coumadin; Epoetin NOS; Vitamin B12; Immune Globulin NOS; Acetaminophen; Ureacin; Omeprazole; Amiodarone HCL; Procardia XL; Prilosec; Nifedipine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Metoclopramide; Levothroid; Coumadin; Coumadin; Calcium Carbonate; Plendil; Acetaminophen; Acetaminophen; Acetaminophen; Benadryl; PEG-3350 and Electrolytes; Cardizem; Prednisone TAB; Atenolol; Reglan; Renagel; Epogen; Pravastatin; Metoprolol Tartrate



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30

Patient: 56 year old female

Reactions: Joint Contracture, Pain, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Depression, Injury, Extremity Contracture, Muscular Weakness, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist

Optimark
    Indication: Disorientation

Magnevist
    Dosage: unk
    Indication: Renal Mass
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Headache

Optimark
    Indication: Muscular Weakness

Other drugs received by patient: Renvela; Prednisone; Lantus; Sensipar; Atenolol; Prograf



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: 56 year old female

Reactions: Pruritus, Abasia, Joint Contracture, Pain, Skin Hyperpigmentation, Ephelides, Joint Stiffness, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Depression, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, Muscular Weakness, General Physical Health Deterioration, Skin Disorder, Skin Induration, Nephrogenic Systemic Fibrosis, Rash, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Indication: Disorientation

Optimark
    Indication: Headache

Magnevist
    Indication: Renal Mass

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Muscular Weakness

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Other drugs received by patient: Lantus; Sensipar; Phoslo; Procrit; Renvela; Prograf; Atenolol; Slow Release Iron; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone TAB



Possible Magnevist side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Excoriation, Muscle Contracture, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Induration, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Renal
    Start date: 2005-08-25
    End date: 2005-08-25

Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Omniscan
    Dosage: unk

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Other drugs received by patient: Cytoxan; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Pentamidine Isethionate; Oxycodone HCL; Wellbutrin; Coumadin; Lopressor; Aspirin; Folic Acid; Flagyl; Acetaminophen; Zaroxolyn; Normodyne; Compazine; Pravachol; Albuterol; Ativan; MS Contin; Fosamax; Thiamine; Calcitriol; Norvasc; Lasix; Darbepoetin Alfa; Heparin; Protonix; Calcitonin Salmon; Labetalol HCL; Renagel; Phoslo; Viagra; Sodium Citrate; Trazodone HCL; Mirapex; Spiriva; Prednisone TAB; Magnesium Oxide; Kayexalate; Lexapro; Lisinopril



Possible Magnevist side effects in 78 year old male

Reported by a consumer/non-health professional from Japan on 2012-05-23

Patient: 78 year old male, weighing 56.0 kg (123.2 pounds)

Reactions: Joint Range of Motion Decreased, Skin Discolouration, Gait Disturbance, Skin Induration, Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: 10 ml, once
    Indication: Diagnostic Procedure
    Start date: 2008-07-29
    End date: 2008-07-29

Prohance
    Dosage: 26 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2008-07-17
    End date: 2008-07-17

Other drugs received by patient: Lasix; Strong NEO-Minophagen C; Lendormin; Omeprazole; Neurotropin [organ Lysate, Standardized]; Antebate; Flomox; Warfarin Sodium; Unasyn; Selbex; Olopatadine HCL; Atarax; Loxonin; Omeprazole; SG Granules; Digoxin; Celestamine TAB; Adalat CC; Zefnart; Metfformin Hydrochloride



Possible Magnevist side effects in 42 year old female

Reported by a physician from United States on 2012-05-23

Patient: 42 year old female

Reactions: Pain, Muscle Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Pigmentation Disorder, Musculoskeletal Stiffness, Fibrosis

Drug(s) suspected as cause:
Optimark
    Indication: Diagnostic Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2008-11-20

Magnevist
    Indication: Diagnostic Procedure

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Diagnostic Procedure

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Headache

Other drugs received by patient: Darunavir Hydrate; Oxycodone HCL; Isentress; Dapsone; Phoslo; Toprol-XL



Possible Magnevist side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Muscular Weakness, General Physical Health Deterioration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Arthralgia, Gait Disturbance, Mobility Decreased, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Other drugs received by patient: Epogen; Renagel; Procardia; Aspirin; Lopressor; Minoxidil; Ferrlecit; Zemplar; Coreg; Norvasc; Calcium Carbonate; Lanthanum Carbonate; Renaphro; Imuran; Digoxin; Florinef; Cortisone Acetate; Plaquenil; Micardis; Amiodarone HCL; Darbepoetin Alfa; Prednisone; Hectorol; Vancomycin; Darbepoetin Alfa; Phoslo; Fosrenol; Clonidine; Percocet; Oxycet



Possible Magnevist side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Arthralgia, Gait Disturbance, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Other drugs received by patient: Prednisone; Imuran; Norvasc; Calcium Carbonate; Micardis; Oxycet; Darbepoetin Alfa; Minoxidil; Percocet; Renagel; Digoxin; Clonidine; Phoslo; Lanthanum Carbonate; Ferrlecit; Florinef; Lopressor; Plaquenil; Procardia; Zemplar; Coreg; Amiodarone HCL; Aspirin; Cortisone Acetate; Renaphro; Epogen; Vancomycin; Darbepoetin Alfa; Hectorol; Fosrenol



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17

Patient: 63 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Muscle Atrophy, Skin Exfoliation, Pain, Sensory Loss, Scleroderma, Pallor, Anhedonia, Skin Discolouration, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Skin Atrophy, Extremity Contracture, Muscle Contracture, Motor Dysfunction, Muscular Weakness, Skin Disorder, Skin Fragility, DRY Skin, Skin Induration, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Emotional Distress, Burning Sensation, Anxiety, Xerosis, Activities of Daily Living Impaired, Arthralgia, Grip Strength Decreased, Asthenia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Magnevist

Other drugs received by patient: Norvasc; Epogen; Vancomycin; Oxycodone HCL; Iron; Calcitonin Salmon; Heparin; Renagel; Lisinopril; Lebacarton; Clindamycin; Colace; Sensipar; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Nephrocaps; Corticosteroids



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16

Patient: 56 year old female

Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Depression, Extremity Contracture, Skin Disorder, Muscular Weakness, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Indication: Renal Mass

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Disorientation

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-06-02
    End date: 2006-06-02

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-05-21
    End date: 2004-05-21

Other drugs received by patient: Sensipar; Atenolol; Prednisone TAB; Prograf; Renvela; Lantus



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017